Expression of a Need of Implication for the Vulnerable Patient and His Adaptation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the research is to detect prematurely vulnerable patients needing a global coverage in integrated care with a created and metrological validated score.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility and Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Handicap

NCT04991558

Disabilities Physical Disabilities Mental

COMPLETED

Measuring the Impact of a Multimodal Intervention on Falls and Fear Falls Among People 65 Years Old, Residents at Home

NCT03968536

Fall Old Age; Atrophy

COMPLETED

Evaluation of a Prototype for an Innovative Room for the Elderly

NCT06098534

Elderly Inpatients

RECRUITING NA

Validation of the Hospital Frailty Score in France

NCT03905629

Elderly Emergency Hospitalization Frailty

COMPLETED

Determining the Needs of Aging People With Disabilities

NCT02735005

Disabled People Aging Mental Handicap

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The respect for the rights of the patients in palliative phase - having an evolutionary or terminal grave pathology - is a legal requirement since 1999, strengthened by the laws of April 4th, 2002 and April 22nd, 2005. Nevertheless, a lack of palliative approach persists, that is premature awareness of the necessity of a global approach, not exclusively centred on the specific therapeutics. The palliative approach remains rare and especially most of the time reduced in the last days of the life. The lack of distribution of the legal texts and insufficient training are among the main reasons. The lack of educational tools is probably also a major brake in a premature reflection.

Primary objective : to detect prematurely vulnerable patients needing a global coverage in integrated care with a created and metrological validated score.

Primary endpoint: capacity of the score to be discriminated (area under the curve) to find the patients who need or not a palliative approach

Secondary objectives:

* The measure of the relevance of the tests of quality of life, personality traits, level of information and anxiety depression to detect prematurely the vulnerable patients and/or their family caregivers who need an approach of palliative care in integrated care;
* The detail (date, nature of the event) of the various stages of their life course, during which the vulnerable patients needing a premature global care were taken care within the framework of such an approach, compared with their theoretical detection by the score of premature detection scale;
* The evaluation of the concordance between the patient score and the family caregiver score, if he participates in the research.

Secondary endpoints:

* The tests estimating the anxiety and the depression ( HAD (Hospital Anxiety and Depression) score), the personality and adaptation traits, Brief Cope;
* The quality of life tests EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire) and level of information EORTC INF-30 (Information-30) for the cancer patients;
* The deadline between detection by the score and effective global care
* The deadline between detection by the score and the cessation of the specific treatments
* The deadline between detection by the score and the death
* The patient and close scores obtained in the validation phase.

Methods: Prospective, controlled, nonrandomized study

Number of patients to include: 610 (maximum)

Duration: 36 months (32 inclusion months).

Number of participating centers: 1 center

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Incurable Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Elaboration of the questionnaires

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Group B

Patients taken care for more less than 6 days by the health care team palliatives EIVA and they eventual family caregiver. Score

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Score

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Intervention Type OTHER

Score

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients hospitalized with:

* an evolutionary incurable disease;
* Taken care for more than a month by the health care team palliatives EIVA (except for the last 200 patients, for whom the deadline extension of palliative care is lower that 6 days);
* Benefiting of asocial scheme or claimant
* Having signed the informed consent as well as his(her) family caregiver, if this one participates in the research.

The absence of family caregiver is not an exclusion criterion.

Exclusion Criteria

* Patient:

* Having difficulty of understanding of the French language
* Having a life expectancy estimated unless one month
* un controlled physical or psychic distress (anxiety and/or depression)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No